Results 11 to 20 of about 87,208 (292)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma

Technology in Cancer Research & Treatment, 2021
Purpose: Induction chemotherapy plus concurrent chemoradiotherapy and concurrent chemoradiotherapy alone are both standard treatment regimens for managing locally advanced nasopharyngeal carcinoma.
Guoqiang Xu MD, Qiaoli Wang MD, Xingrao Wu MD, Chunyan Lv MD, Guilin Zeng MD, Zhihong Xue MD, Ruixue Cao MD, Nan Zhang BD, Wei Xiong PhD, Qin Huang MD   +9 more
doaj   +1 more source

Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma

Frontiers in Oncology, 2021
PurposeTo identify whether chemoradiotherapy improves survival of stage I nasopharyngeal carcinoma (NPC).Materials and MethodsNPC patients were extracted from the Surveillance, Epidemiology, and End Results database between 2010 and 2015.
Jia-Lin Ma, Shi-Ting Huang, Yan-Ming Jiang, Xin-Bin Pan   +3 more
doaj   +1 more source

The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

Medicina, 2021
Background and Objectives: There is evidence or consensus on the use of 18F-2-fluorodeoxyglucose-positron emission tomography with computed tomography (PET-CT) in evaluating the effects of treatment at 12 weeks after chemoradiotherapy for head and neck ...
Hoshino Terada, Yuzo Shimode, Madoka Furukawa, Yuichiro Sato, Nobuhiro Hanai   +4 more
doaj   +1 more source

Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials

Frontiers in Oncology, 2022
ObjectivesTo assess the clinical efficacy and toxicity of nimotuzumab in combination with chemoradiotherapy or chemoradiotherapy alone in the treatment of cervical cancer.MethodsThe PubMed, Embase, Cochrane Library, Web of Science, China National ...
Yan Yuan, Yan Yuan, Jiuzhou Chen, Jiuzhou Chen, Miao Fang, Miao Fang, Yaru Guo, Yaru Guo, Xueqing Sun, Xueqing Sun, Dehong Yu, Yilong Guo, Yong Xin, Yong Xin   +13 more
doaj   +1 more source

Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients

World Journal of Surgical Oncology, 2020
Background The proline-rich protein 11 (PRR11) is a newly identified oncogene associated with a poor prognosis in several human cancers. Nonetheless, research on its role in ovarian cancer (OC) remains largely understudied.
Yu Zhan, Xueyuan Wu, Gang Zheng, Jingjing Jin, Chaofu Li, Guanzhen Yu, Wenfeng Li   +6 more
doaj   +1 more source

Outcome of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in non-metastatic locally advanced non-small cell lung cancer – A prospective and randomized study

Asian Journal of Medical Sciences, 2023
Background: Sequential chemoradiotherapy and concurrent chemoradiotherapy are two treatment options for locally advanced non-small cell lung cancer (NSCLC). Still there is limited data regarding which is the better treatment option.
Subir Pal , Anjan Bera , Soumen Mukherjee , Asmita Dasgupta , Srikrishna Mandal , Saptarshi Banerjee   +5 more
doaj   +1 more source

Chemoradiotherapy of esophageal carcinoma [PDF]

Cancer, 1994
Chemoradiotherapy has demonstrated efficacy in esophageal cancer but rarely is curative. To improve local control and decrease metastases, a 7-month regimen was used with standard-dose radiotherapy (RT), cisplatin (DDP), and continuous infusion (CI) 5-fluorouracil (5-FU) in patients with locoregional squamous/adenocarcinoma of the esophagus.Initial ...
E A, Poplin, P S, Khanuja, M J, Kraut, A M, Herskovic, P B, Lattin, G, Cummings, L E, Gaspar, J L, Kinzie, Z, Steiger, V K, Vaitkevicius   +9 more
openaire   +2 more sources

CHEMORADIOTHERAPY FOR COLORECTAL CANCER [PDF]

Gut, 2005
Recent estimates for cancer incidence and mortality in Europe continue to rank colorectal cancer as the second most common cause for cancer related death. Every year more than 376 000 patients are newly diagnosed with colorectal cancer and approximately 200 000 people die from the disease.1 Even though these numbers show a slight decrease,2,3 partially
N, Andre, W, Schmiegel
openaire   +2 more sources

Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells

Genes and Diseases, 2020
The phenomenon of enhanced invasion and metastasis of residual tumor cells has been observed in an increasing number of patients receiving chemoradiotherapy recently, and tumor metastasis will undoubtedly limit patient prognosis.
Wei Xiong, Yong Liao, Ji-Yong Qin, Wen-Hui Li, Zhao-You Tang   +4 more
doaj   +1 more source

A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma

Heliyon
Sphingolipid metabolism affects prognosis and resistance to immunotherapy in patients with cancer and is an emerging target in cancer therapy with promising diagnostic and prognostic value.
Xiaolan He, Zhengyang Xu, Ruiping Ren, Peng Wan, Yu Zhang, Liangliang Wang, Ying Han   +6 more
doaj   +1 more source